Merck & Co., Inc. - MRK Stock Forecast, Price & News

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck & Co., Inc. in the last year. There are currently 4 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MRK shares.
View MRK analyst ratings or view top-rated stocks.

17 analysts have issued 1-year price targets for Merck & Co., Inc.'s stock. Their MRK share price forecasts range from $93.00 to $122.00. On average, they anticipate the company's stock price to reach $106.00 in the next twelve months. This suggests that the stock has a possible downside of 3.7%.
View analysts price targets for MRK or view top-rated stocks among Wall Street analysts.

Merck & Co., Inc.'s stock was trading at $76.64 at the beginning of the year. Since then, MRK stock has increased by 43.6% and is now trading at $110.04.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our MRK earnings forecast.

Merck & Co., Inc. (NYSE:MRK) issued its earnings results on Thursday, October, 27th. The company reported $1.85 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.67 by $0.18. The company earned $14.96 billion during the quarter, compared to the consensus estimate of $14.05 billion. Merck & Co., Inc. had a trailing twelve-month return on equity of 46.57% and a net margin of 25.88%. The firm's revenue was up 13.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.75 earnings per share.
Read the conference call transcript.

Merck & Co., Inc. announced a quarterly dividend on Tuesday, November 29th. Stockholders of record on Thursday, December 15th will be paid a dividend of $0.73 per share on Monday, January 9th. This represents a $2.92 dividend on an annualized basis and a yield of 2.65%. The ex-dividend date is Wednesday, December 14th. This is a positive change from the stock's previous quarterly dividend of $0.69.
Read our dividend analysis for MRK.

Merck & Co., Inc. (NYSE:MRK) pays an annual dividend of $2.76 per share and currently has a dividend yield of 2.51%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 45.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MRK will have a dividend payout ratio of 37.60% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MRK.

Merck & Co., Inc. issued an update on its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share guidance of $7.32-$7.37 for the period, compared to the consensus EPS estimate of $7.34. The company issued revenue guidance of $58.50 billion-$59.00 billion, compared to the consensus revenue estimate of $58.51 billion.

1,343 employees have rated Merck & Co., Inc. Chief Executive Officer Kenneth C. Frazier on Glassdoor.com. Kenneth C. Frazier has an approval rating of 94% among the company's employees. This puts Kenneth C. Frazier in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Merck & Co., Inc. investors own include Pfizer (PFE), Johnson & Johnson (JNJ), AT&T (T), Intel (INTC), Cisco Systems (CSCO), Walt Disney (DIS), Verizon Communications (VZ), JPMorgan Chase & Co. (JPM), AbbVie (ABBV) and Home Depot (HD).

Merck & Co., Inc. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRK."

Merck & Co., Inc.'s stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.84%), BlackRock Inc. (8.46%), State Street Corp (4.63%), Bank of New York Mellon Corp (1.22%), Massachusetts Financial Services Co. MA (1.07%) and Price T Rowe Associates Inc. MD (0.60%). Insiders that own company stock include Caroline Litchfield, Frank Clyburn, Johannes Jacobus Oosthuizen, Julie L Gerberding, Kenneth C Frazier, Richard R Deluca, Rita A Karachun, Robert M Davis, Sanat Chattopadhyay, Steven Mizell and Wendell P Weeks.
View institutional ownership trends.

Shares of MRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MRK stock can currently be purchased for approximately $110.04.

Merck & Co., Inc. (NYSE:MRK) has a market capitalization of $279.00 billion and generates $48.70 billion in revenue each year. The company earns $13.05 billion in net income (profit) each year or $6.01 on an earnings per share basis.

The company employs 68,000 workers across the globe.

Merck & Co., Inc.'s mailing address is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. The official website for the company is www.merck.com. The company can be reached via phone at (908) 740-4000, via email at investor_relations@merck.com, or via fax at 908-735-1253.